Skip To Main Content |
-A A +A

Liposomal Amphotericin-B - Sucess Story

FUNGISOMETM, India’s first Liposomal Amphotericin B developed by employing DBT technology was transferred to M/s. Lifecare Innovations Pvt. Ltd. by NRDC.  The technology was licensed to the company to commercialise and further improve the formulation to overcome the doses related toxicities of Amphotericin-B as compared to the imported lipid formulations such as AmBisome, Ampholip (Abelcet) and Amphocil (Amphotek).  Today as claimed by Lifecare Innovations Pvt. Ltd., Fungisome is the least toxic drug available in the country in its category